Skip to Content

Mebrofenin Pregnancy and Breastfeeding Warnings

Mebrofenin is also known as: Choletec

Mebrofenin Pregnancy Warnings

Animal reproduction studies have not been conducted.

It is not known whether Tc99m mebrofenin can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity.

FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

FDA pregnancy category: C

Use mebrofenin only if clearly needed and benefit outweighs potential risk.

See references

Mebrofenin Breastfeeding Warnings

The manufacturer recommends substitution of formula feedings for breast feedings.

Breast-feeding is not recommended.

Excreted into human milk: Yes
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Choletec (mebrofenin)." Bracco Diagnostics Inc, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Choletec (mebrofenin)." Bracco Diagnostics Inc, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide